L2nd June 2017
Dear Marapharm Shareholder,
It has come to
L2nd June 2017
Dear Marapharm Shareholder,
It has come to our attention, that emails are being sent to shareholders from an anonymous source to discredit, manipulate and slander Marapharm and people associated with it. Message boards are also being filled up with untrue and slanderous information.
You may have received one of these emails or have read a message board. We can only assume that it is positioning to short the stock or that some person or group is wanting to see our company fail . When people short the stock it drives the price down, which in turn, hurts you the shareholder.
Everyone affiliated with Marapharm is professional and has the company's and its shareholders interest at heart. Brian Lovig facilitated the founding of Marapharm and has consulted for us on a regular basis since inception which has been instrumental in helping us achieve many of our goals.
Marapharm is doing well. Success is often attacked. There were 3 cannabis licenses issued during this last week! They are posted on the website for you to view.
Thank you, we appreciate your continued support. Please be assured that your personal information has always been protected by the Company and we are investigating how this information was fraudulently obtained.
Linda Sampson
Fiore Cannabais Ltd. (FIORF) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...
Continue Reading
A New Gadget Promises Big Savings in Time and Effort Ever wrestled with a hydraulic hose and felt like you were arm wrestling a gorilla? Well, it looks like there's a new gadget on the scene that might save you from that struggle. Straight from Menomonie, Wisconsin, we’ve got a slick new tool hitting the market called THE VALVE TOOL. The idea is simple but effective:...
Continue Reading
Tax Strategy: Not All About April 15 Ready to fend off that taxman? Well, don’t just wait for that dreaded April deadline. Greg Harrison over at Harrison Financial Management spills some wisdom on the oft-overlooked nuances between tax planning and tax preparation. It’s not just semantics; it’s the difference between shaping your financial future and simply...
Continue Reading
Leadership Recognized: Wendy C. Wilson's Impact Some folks know their way around the trenches of corporate battle, and Wendy C. Wilson is one of them. Known for her grit and savvy, she now takes a coveted spot in The Inner Circle of Excellence as a Pinnacle Professional Member. This title isn't just for show—it's a hat tip to her powerhouse contributions as a speaker on...
Continue Reading
A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...
Continue Reading
A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...
Continue Reading
Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...
Continue Reading
They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...
Continue Reading
Sometimes the gears of progress grind slowly, but that's part of the deal in the mining game. For Century Lithium Corp., the completion of the Mine Plan of Operations (PoO) for the Angel Island Project marks a big step forward—or at least, it gets them ready for the next round of bureaucratic wrangling under the NEPA. Let's dissect what this means as they march toward...
Continue Reading
An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...
Continue Reading
Top 5 Most Recently Viewed Articles
Qatar Airways Expands Presence at JFK Airport Qatar Airways is set to enhance its operations at John F. Kennedy International Airport by moving to the New Terminal One, which promises a first-of-its-kind experience for travelers in the United States. This airline, renowned for its exceptional service, is preparing to introduce a dedicated lounge in 2026, significantly...
Continue Reading
Venture Global Faces Legal Action Venture Global, Inc. has recently been embroiled in a securities class action lawsuit filed in the Southern District of New York. The lawsuit pertains to all individuals or entities who acquired Venture's securities during its initial public offering around January 2025, seeking to recover damages under federal securities laws. Claims of...
Continue Reading
Aclaris Therapeutics R&D Day Focused on Patient Needs Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical organization based in Pennsylvania, is set to host its highly anticipated R&D Day. This event is dedicated to exploring the evolving landscape of immuno-inflammatory diseases and the innovative solutions that the company is developing. The R&D Day will take...
Continue Reading
Cloudelligent Celebrates Top Ranking in MSP 501 Cloudelligent, a prominent Managed Cloud Services provider, has reached an impressive milestone by being recognized as the sixth-ranked company on Channel Futures' prestigious MSP 501 list for the year. This distinction is not merely a testament to their robust performance; it underscores their relentless commitment to...
Continue Reading
Lithia Motors Reports Strong Financial Performance Why are Lithia Motors, Inc.‘s shares slipping despite a substantial earnings beat and impressive profitability growth? As investors grapple with mixed signals from the company’s latest financial performance, the story behind the numbers holds the key to understanding market reactions. Lithia Motors shares are trading...
Continue Reading